ArticleEuropean urology2019
Re: Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Jiasian Teh et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleEuropean urology2019
Jiasian Teh et al.PubMed ↗Publisher ↗
No numbers read from the abstract.